The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework

Arthur C. Macedo; Cécile Tissot; Joseph Therriault; Stijn Servaes; Yi-Ting Wang; Jaime Fernandez-Arias; Nesrine Rahmouni; Firoza Z. Lussier; Marie Vermeiren; Gleb Bezgin; Paolo Vitali; Kok Pin Ng; Eduardo R. Zimmer; Marie-Christine Guiot; Tharick A. Pascoal; Serge Gauthier; Pedro Rosa-Neto

doi:10.2967/jnumed.122.265200

Research ArticleState of the Art

Open Access

The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework

Arthur C. Macedo, Cécile Tissot, Joseph Therriault, Stijn Servaes, Yi-Ting Wang, Jaime Fernandez-Arias, Nesrine Rahmouni, Firoza Z. Lussier, Marie Vermeiren, Gleb Bezgin, Paolo Vitali, Kok Pin Ng, Eduardo R. Zimmer, Marie-Christine Guiot, Tharick A. Pascoal, Serge Gauthier and Pedro Rosa-Neto

Journal of Nuclear Medicine August 2023, 64 (8) 1171-1178; DOI: https://doi.org/10.2967/jnumed.122.265200

Arthur C. Macedo

1Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Cécile Tissot

1Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Joseph Therriault

1Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stijn Servaes

1Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yi-Ting Wang

1Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jaime Fernandez-Arias

1Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nesrine Rahmouni

1Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Firoza Z. Lussier

2Department of Psychiatry and Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marie Vermeiren

1Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gleb Bezgin

1Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Paolo Vitali

1Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kok Pin Ng

3Department of Neurology, National Neuroscience Institute, Singapore, Singapore;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Eduardo R. Zimmer

4Department of Pharmacology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marie-Christine Guiot

5Department of Pathology, McGill Hospital Center, Montréal, Québec, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tharick A. Pascoal

2Department of Psychiatry and Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Serge Gauthier

1Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pedro Rosa-Neto

1Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 64, Issue 8

August 1, 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework

Journal of Nuclear Medicine Aug 2023, 64 (8) 1171-1178; DOI: 10.2967/jnumed.122.265200

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework

Journal of Nuclear Medicine Aug 2023, 64 (8) 1171-1178; DOI: 10.2967/jnumed.122.265200

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

Comparison Between Brain and Cerebellar Autoradiography Using [18F]Flortaucipir, [18F]MK6240, and [18F]PI2620 in Postmortem Human Brain Tissue
PET Imaging in Alzheimer Disease: Pathology and Research Insights for Technologists
Cascaded Multimodal Deep Learning in the Differential Diagnosis, Progression Prediction, and Staging of Alzheimers and Frontotemporal Dementia
MU-BRAIN: MUltiethnic Brain Rna-seq for Alzheimer INitiative
Drosophila appear resistant to trans-synaptic tau propagation
Cryo-EM structure of Alzheimers disease tau filaments with PET ligand MK-6240

Google Scholar

Keywords

Alzheimer disease
Braak staging
PET
neurofibrillary tangles
cognitive impairment

Main menu

User menu

Search

The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords